Related Experiment Video
Updated: Sep 4, 2025

09:10
Synthesis of Indoxyl-glycosides for Detection of Glycosidase Activities
Published on: May 27, 2015
6.7K
Responsive Fluorescent Coumarin-Cinnamic Acid Conjugates for α-Glucosidase Detection
Dong Luo1, Xin Zhang1, Xiaoying Li1
1School of Biotechnology and Health Science, Wuyi University, Jiangmen, China.
Frontiers in Chemistry
|July 15, 2022
Summary
Researchers developed new fluorescent probes, LD01 and LD02, for detecting alpha-glucosidase (an enzyme targeted in type II diabetes). Probe LD02 showed enhanced fluorescence upon binding, aiding inhibitor evaluation.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Analytical Chemistry
Background:
- Alpha-glucosidase (α-glucosidase) is a key therapeutic target for type II diabetes mellitus.
- Development of selective α-glucosidase inhibitors often relies on natural product scaffolds.
- Efficient fluorescent probes for α-glucosidase detection, especially those with inhibitory capabilities, remain limited.
Purpose of the Study:
- To design and synthesize novel, environmentally sensitive fluorescent probes for highly specific α-glucosidase detection.
- To create probes with potential dual functionality as detection tools and inhibitor evaluation agents.
Main Methods:
- Synthesis of two fluorescent probes, LD01 and LD02, utilizing coumarin and cinnamic acid derivatives.
- Evaluation of probe responsiveness and binding affinity to α-glucosidase through fluorescence emission studies.
Main Results:
- The synthesized probes, LD01 and LD02, exhibited environmentally sensitive fluorescence.
- Probe LD02 demonstrated a significant and responsive enhancement in emission upon binding to α-glucosidase.
- The probes proved effective in assessing the binding affinity of α-glucosidase inhibitors.
Conclusions:
- Novel fluorescent probes LD01 and LD02 were successfully designed and synthesized.
- LD02 serves as an efficient tool for the specific detection of α-glucosidase.
- These probes facilitate the evaluation of α-glucosidase inhibitor binding affinities, advancing diabetes research.

